Improving the Diagnosis and Management of Lewy Body Dementia | Professor John O'Brien

Lewy body dementia, comprising both dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD), has an even worse outcome than other dementias in terms of functional decline, reduced quality of life and increased mortality. Despite revisions in diagnostic criteria and the availability of some diagnostic biomarkers, many cases remain misdiagnosed. There are some effective treatments for Lewy body dementia and its symptoms, but there is considerable heterogeneity in approaches to management. This lecture updates current thinking on how to improve both diagnosis and management, and describes results of a recent study which has developed new management guidelines to assist clinicians to optimise management of people who have Lewy body dementia.

[@gvet47]

Just learned of a close friend thst got this type I had never heard of. What I read is people die in four years. Sad for snother form

[@osojenjen]

Have there been studies on patients combining NM dopamine transporter imaging, NM MIBG SPECT imaging, and PET FDG imaging?